Lung cancer screening guidelines do not exist for individuals who never smoked, but data presented at International ...
The FANSS shows a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history, which is comparable to ...
The AIM-HIGH trial showed significant DFS improvement in high-risk stage 1a to 2a nonsquamous NSCLC patients receiving adjuvant chemotherapy. At 24 months, 96% of chemotherapy patients were alive ...
MedPage Today on MSN
Video-Assisted Surgery Improves Survival in Early Lung Cancer
Patients undergoing video-assisted thoracoscopic surgery (VATS) for early-stage lung cancer had improved overall survival (OS ...
Patients with limited-stage small cell lung cancer with detectable ctDNA after chemotherapy derived a significant survival ...
Video-assisted thoracoscopic surgery demonstrated superior overall survival than open lobectomy in patients with early-stage lung cancer.
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
AstraZeneca’s Imfinzi (durvalumab) has been approved for NHS use in England and Wales for adults with limited-stage small ...
In patients treated with surgery, survival rates were comparable for those aged 75 to 80 years and for younger patients.
Merck has shared positive results from the Phase II IDeate-Lung01 trial (NCT05280470) evaluating ifinatamab deruxtecan (I-DXd) in patients with previously treated extensive-stage small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback